Siemens Launches Advia Centaur Tests In Europe
Siemens has launched a new device in Europe for prostate cancer testing, which is designed to offer improved detection rates. The Advia Centaur free prostate-specific antigen (PSA) tests have been released after receiving CE-mark accreditation and complete a full menu of prostate cancer tests available from Siemens.
Read the full story here.
-
Siemens Leads By Example In IVD Industry Through Adopting GS1 Standards For Healthcare Product Identification
Biohit releases two new quick tests
Pathologists call for standardization of cancer tests
Helix And Genelex To Increase Availability Of DNA Drug Sensitivity Tests
Roche Receives FDA Clearance For U.S. Launch Of Cobas 8000 Modular Analyzer Series For High-Volume Laboratory Testing
